Table 5.
Associations between maternal vitamin B12 status and infant methylmalonic acid
Maternal variables | Trimester (T) | Model 1a | Model 2b | |||
---|---|---|---|---|---|---|
n | Beta (s.e.m.) | P-value | Beta (s.e.m.) | P-value | ||
Plasma vitamin B12,c pmol/l | T1 | 76 | −0.43 (0.23) | 0.060 | −0.41 (0.26) | 0.113 |
T2 | 63 | −0.55 (0.20) | 0.006 | −0.52 (0.20) | 0.009 | |
T3 | 58 | −0.55 (0.20) | 0.006 | −0.49 (0.20) | 0.016 | |
Vitamin B12 < 150 pmol/l | T1 | 76 | 0.47 (0.23) | 0.036 | 0.49 (0.25) | 0.046 |
T2 | 63 | 0.65 (0.23) | 0.005 | 0.66 (0.23) | 0.004 | |
T3 | 58 | 0.80 (0.26) | 0.002 | 0.76 (0.26) | 0.004 | |
Plasma MMA,c μmol/ | T1 | 76 | 0.46 (0.16) | 0.003 | 0.47 (0.16) | 0.003 |
T2 | 63 | 0.60 (0.18) | 0.001 | 0.64 (0.17) | < 0.001 | |
T3 | 58 | 0.36 (0.16) | 0.022 | 0.32 (0.16) | 0.049 | |
MMA >0.26 μmol/l | T1 | 76 | 0.66 (0.23) | 0.005 | 0.63 (0.24) | 0.008 |
T2 | 63 | 0.56 (0.24) | 0.020 | 0.66 (0.24) | 0.006 | |
T3 | 58 | 0.46 (0.25) | 0.062 | 0.42 (0.25) | 0.084 | |
Impaired vitamin B12 Statusd | T1 | 76 | 0.54 (0.23) | 0.018 | 0.51 (0.23) | 0.029 |
T2 | 63 | 0.63 (0.23) | 0.006 | 0.68 (0.22) | 0.002 | |
T3 | 58 | 0.72 (0.25) | 0.004 | 0.68 (0.25) | 0.007 | |
Plasma tHcy,c μmol/l | T1 | 76 | 0.26 (0.15) | 0.090 | 0.24 (0.16) | 0.140 |
T2 | 63 | 0.34 (0.18) | 0.063 | 0.34 (0.20) | 0.083 | |
T3 | 58 | −0.03 (0.19) | 0.869 | −0.01 (0.19) | 0.951 | |
cB12e | T1 | 76 | −0.36 (0.12) | 0.003 | −0.35 (0.12) | 0.005 |
T2 | 63 | −0.35 (0.12) | 0.003 | −0.37 (0.13) | 0.004 | |
T3 | 58 | −0.29 (0.13) | 0.030 | −0.33 (0.14) | 0.016 | |
Erythrocyte folate,c nmol/l | T1 | 76 | −0.87 (0.30) | 0.004 | −0.94 (0.29) | 0.001 |
T2 | 63 | −0.65 (0.34) | 0.058 | −0.74 (0.35) | 0.036 | |
T3 | 58 | −1.58 (0.42) | 0.0002 | −1.50 (0.42) | < 0.001 |
Abbreviations: BMI, body mass index; MMA, methylmalonic acid; SLI, standard of living index; tHcy, total homocysteine.
Statistical analyses: linear regression models were used to examine associations between maternal vitamin B12 status and infant methylmalonic acid concentrations; models were adjusted for vitamin B12 supplementation and gestational age of sample collection.
Statistical analyses: linear regression models were used to examine associations between maternal vitamin B12 status and infant methylmalonic acid concentrations; models were adjusted for vitamin B12 supplementation, gestational age of sample collection, maternal education (⩾ 10th grade vs <10), SLI (⩾ 28 vs <28), baseline total lymphocyte count, baseline BMI.
Natural logarithmically transformed to achieve normality.
Impaired vitamin B12 status: plasma vitamin B12<150 pmol/l plus MMA>0.26 μmol/l.
cB12, a combined indicator of vitamin B12 status modified for three biomarkers (vitamin B12, MMA and tHcy), was calculated using the method developed by Fedosov et al.20